Hims & Hers Health Inc (NYSE:HIMS) shares traded 6.85% higher at $27.77 on Wall Street last session.
HIMS stock price is now -29.09% away from the 50-day moving average and 5.67% away from the 200-day moving average. The market capitalization of the company currently stands at $6.17B.
With the price target enhanced from $42 to $60, Morgan Stanley Downgraded its rating from Overweight to Equal-Weight for Hims & Hers Health Inc (NYSE: HIMS). On January 10, 2025, Citigroup Downgraded its previous ‘Neutral’ rating to ‘Sell’ on the stock increasing its target price from $24 to quote $25, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Becklund Irene, PAO sold 2,203 shares of the company’s stock on Apr 03 ’25. The stock was sold for $63,402 at an average price of $28.78. Upon completion of the transaction, the PAO now directly owns 8,007 shares in the company, valued at $0.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 02 ’25, Chief Financial Officer Okupe Oluyemi sold 11,581 shares of the business’s stock. A total of $338,833 was realized by selling the stock at an average price of $29.26. This leaves the insider owning 124,104 shares of the company worth $3.45 million. A total of 18.09% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $11.20 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 1.79, and a quick ratio of 1.50. According to the stock market information, the enterprise value for the company is $5485177344, which is based on a 51.93 price-to-earnings ratio, a 1.67 price-to-earnings-growth ratio, and a beta of 1.84. The fifty day moving average price for HIMS is $39.1644 and a two-hundred day moving average price translates $26.2792 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-12-31. The net profit margin was 8.54% and return on equity was 30.71% for HIMS. The company reported revenue of $481.14 million for the quarter, compared to $246.62 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 95.09 percent.
